Summary:
Click image to enlargeLocal doctors at Syrentis Clinical Research are conducting a study evaluating an investigational medication for agitation in people living with Alzheimer’s disease is now enrolling.
Qualified Participants Must:
• Be aged 65-90
•
Be diagnosed with Alzheimer's
•
Be experiencing agitation, irritability or aggression associated with Alzheimer's
•
Additional criteria may apply
Qualified Participants May Receive:
Study-related care and study medication will be provided to qualified participants. Compensation for time and travel will be available.